WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeFundsValueAct Capital › Q4 2010

ValueAct Capital 13F holdings, Q4 2010

Holdings as of December 31, 2010 · filings on SEC EDGAR · latest filing →

ValueAct Capital disclosed 12 US equity positions worth $3.8bn in its Q4 2010 13F filing. The largest position was VALEANT PHARMACEUTICALS INTL at 19.8% of the reported book, followed by SARA LEE CORP and IT. Against the Q3 2010 filing, it opened 3 new positions, added to 1 and reduced 3 among the top 12 holdings.

← Q3 2010 · Q1 2011 →

What did ValueAct Capital own in Q4 2010? Top 12 positions

#StockSectorWeightValueSharesΔ sharesvs Q3 2010
1 VALEANT PHARMACEUTICALS INTL 19.8%$762.7m26,959,901 new
2 SARA LEE CORP 15.9%$611.4m34,918,822 0% held
3 IT GARTNER INC Technology 14.5%$557.4m16,790,013 0% held
4 C R BARD INC 11.0%$423.2m4,611,139 9% added
5 VRSN VERISIGN INC Technology 9.5%$367.0m11,232,069 -5% reduced
6 WILLIS GROUP HOLDINGS PUBLIC 7.8%$299.8m8,656,910 0% held
7 SNA SNAP ON INC Industrials 6.0%$232.1m4,101,780 -11% reduced
8 ALERE INC 4.7%$181.6m4,960,497 -5% reduced
9 MCO MOODYS CORP Financial Services 4.2%$162.2m6,113,200 new
10 IMMUCOR INC 3.9%$149.5m7,540,665 0% held
11 NYT NEW YORK TIMES CO Communication Services 1.8%$68.6m7,000,000 new
12 OPLN KAR AUCTION SVCS INC Consumer Cyclical 0.8%$31.2m2,258,828 0% held

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.